Tag: FDA guidance
Modified-Release Bioequivalence: Special Considerations for Regulatory Approval
Explore the complex regulatory and technical considerations for bioequivalence studies of modified-release formulations, including FDA vs EMA guidelines, pharmacokinetic parameters, and development challenges.